CLINICAL MATTERS Delta plus is a word combination that sent many people into a panic when it was reported in media in October. To those familiar with the havoc that the Delta variant wreaked in India and globally, the only thing that could possibly be worse is the Delta plus. Delta plus, or...
The Department of Science and Technology (DOST) said Sunday, Oct. 31, that the eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in...
Clinical Matters Nothing is more contentious these days than the discussion surrounding additional doses of COVID-19 vaccines. Israel, having reached a high level of vaccination for its citizens, started offering boosters to its elderly population early on, followed by younger and younger age...
The Philippines has conducted clinical studies to determine the efficacy of virgin coconut oil (VCO) as adjunct treatment against coronavirus disease (COVID-19). (MANILA BULLETIN FILE PHOTO ) Department of Science and Technology (DOST) Undersecretary for Research and Development (R&D) Dr....
The country’s clinical trials on the use of virgin coconut oil (VCO), lagundi (Chinese chaste tree) and tawa-tawa (Euphorbia hirta) as adjunct therapy, herbal medicine, and adjunctive treatment against coronavirus disease (COVID-19) may benefit the country’s farmers, the Department of Science...
The Department of Science and Technology (DOST) said Saturday, Oct. 23, said the recruitment of over 1,400 participants for the eight month-long clinical Ivermectin clinical trials is expected to start in November, and that the initial results of the study may be out by end of December this year....
Bracing for “good results,” the Department of Science and Technology (DOST) said Thursday, Oct. 21, that the drug developers and the public are expected to benefit from the country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug...
Our economy might’ve taken a hit, but we have one of the lowest mortality rates in the world CLINICAL MATTERS At the start of the pandemic last year, each country had to make hard choices in terms of its response to an unknown virus that was spreading fast. The rapid propagation of what was then...
Tawa-tawa (Euphorbia hirta) extract is proving to be an effective adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases, the Department of Science and Technology (DOST) disclosed. Tawa-tawa (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development...
Using lagundi as herbal medicine for mild coronavirus disease (COVID-19) patients yielded positive results, the Department of Science and Technology (DOST) said. Lagundi (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&D) Rowena Cristina Guevara bared the initial...
The country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in isolation facilities will begin on Oct. 15, the Department of Science and Technology...
Here are the new medicines at the forefront in the fight against COVID CLINICAL MATTERS Since the original SARS coronavirus was first discovered in February 2003, scientists have been hard at work looking for effective treatments against deadly coronaviruses. The first promising treatments included...
